ARS Pharmaceuticals
SPRY
SPRY
72 hedge funds and large institutions have $200M invested in ARS Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
30% less capital invested
Capital invested by funds: $287M → $200M (-$87M)
Holders
72
Holding in Top 10
1
Calls
$406K
Puts
–
Top Buyers
| 1 | +$5.01M | |
| 2 | +$2.73M | |
| 3 | +$2.34M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$2.28M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2M |
Top Sellers
| 1 | -$16.7M | |
| 2 | -$3.56M | |
| 3 | -$2.75M | |
| 4 |
Millennium Management
New York
|
-$2.39M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.38M |